This is the first F2F meeting in the DS & AI group and I am happy to participate as member of the DS3 sub team.

it was great meeting you during the DS&AI event in Madrid. I'd be happy if you get in touch with me, ☕️ if you want to drink a coffee or 💊 if you want chat about digital transformation in chemical & pharmaceutical drug development 🐶🌎🧪📸 🧘‍♀️🏔️🧑‍🍳🚐 🍱

I'm member of the Product Owner Hub in the Cell and Gene Therapy and new Modalities team. I'm responsible for the lab automation in DDS. In my role as Business Owner of different IT systems I'm working on the digital roadmap of DDS. I'm also member of the CLJ product team and the Digital Chemistry product team. I'm looking forward to meet the colleagues of DS&AI from all over the world.

I lead the DS3 India group of DS &AI as well as site lead of Bayer Pharma R&D India I manage a group of people with skills like product owner, SCRUM MASTER, Business Analyst , Programmer, Soft ware Developer.

Nico Bernsmeier PhD, Head of Product Owner Modalities and CGT. Trained Molecular Biologist. Joined Bayer 14 years ago. I am passionate about bringing the digital world to the labs. I love the challenge of combining the scientifc aspiration of R&D with the hard reality of IT. Creating a work environement where our product teams can excel in driving their products forward is the challenge we face.

Nice to meet you!

I am heading the Data Assets and Insights Solutions team focusing on creating impact on our pipeline with FAIRified, enriched, semantically integrated data products (e.g., Hubble) in combination with solutions which provide insights to key scientific and business questions along the entire R&D value chain (e.g. Aelixir).

Part of the Clinical Trial Technology and strategy group. Bringing new technology and services to our organisation